A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), although the company says there are ...
The current price of Synapse (SYN) is $0.049009, as of Feb 21, 2026. Over the last 24 hours, the price has moved by 0.24%, with a change of 0.14% in the past hour. For longer-term performance, the ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results